BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 31229495)

  • 1. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
    Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
    Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
    Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
    Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Killer Cell Immunoglobulin-like Receptor Genes and Their HLA Ligands in Iranian Patients with Ankylosing Spondylitis.
    Mahmoudi M; Jamshidi AR; Karami J; Mohseni A; Amirzargar AA; Farhadi E; Ahmadzadeh N; Nicknam MH
    Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):27-38. PubMed ID: 26996109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
    Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
    PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
    Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
    Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
    Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killer cell immunoglobulin like receptor gene association with tuberculosis.
    Pydi SS; Sunder SR; Venkatasubramanian S; Kovvali S; Jonnalagada S; Valluri VL
    Hum Immunol; 2013 Jan; 74(1):85-92. PubMed ID: 23073291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.
    Bernson E; Hallner A; Sander FE; Wilsson O; Werlenius O; Rydström A; Kiffin R; Brune M; Foà R; Aurelius J; Martner A; Hellstrand K; Thorén FB
    Leukemia; 2017 Dec; 31(12):2552-2559. PubMed ID: 28529313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
    Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
    Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
    Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.
    Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C
    Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of killer cell immunoglobulin-like receptors in the Greek population.
    Niokou D; Spyropoulou-Vlachou M; Darlamitsou A; Stavropoulos-Giokas C
    Hum Immunol; 2003 Dec; 64(12):1167-76. PubMed ID: 14630399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.
    Levinson RD; Yung M; Meguro A; Ashouri E; Yu F; Mizuki N; Ohno S; Rajalingam R
    PLoS One; 2016; 11(8):e0160392. PubMed ID: 27490240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and KIR polymorphisms affect NK-cell anti-tumor activity.
    Passweg JR; Huard B; Tiercy JM; Roosnek E
    Trends Immunol; 2007 Oct; 28(10):437-41. PubMed ID: 17825623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of KIR expression and HLA ligands in CD56+ lymphocytes of drug resistant tuberculosis patients.
    Mousavi T; Shahsavar F; Farnia P; Tajik N; Soofi M
    Iran J Allergy Asthma Immunol; 2011 Sep; 10(3):189-94. PubMed ID: 21891825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.
    Varbanova V; Naumova E; Mihaylova A
    Cancer Immunol Immunother; 2016 Apr; 65(4):427-40. PubMed ID: 26874942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.
    Charoudeh HN; Terszowski G; Czaja K; Gonzalez A; Schmitter K; Stern M
    Eur J Immunol; 2013 Feb; 43(2):480-7. PubMed ID: 23161492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
    Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
    Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.